News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

International Technidyne Corporation (THOR) Says CMS Decision to Expand Coverage for INR Self-Testing Will Increase the Market Opportunity for its ProTime(R) Microcoagulation System


4/8/2008 10:00:46 AM

EDISON, N.J.--(BUSINESS WIRE)--International Technidyne Corporation (ITC), a subsidiary of Thoratec Corporation (NASDAQ:THOR), today said the recent decision by the Centers for Medicare & Medicaid Services (CMS) to expand reimbursement for home prothrombin time monitoring will increase the market opportunity for its ProTime offering.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES